Pharmaceuticals North America

North America Veterinary Drugs Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Veterinary Drugs Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $19.04 Bn Placeholder estimate
Estimate 2025 $20.16 Bn 46.3% of the global market
Projected 2034 $33.78 Bn 67.5% Adds $13.61 Bn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 37% of 183 Pharmaceuticals markets here
Key players 6 +1
  • North America is 46.35% of the global market.
  • Among regions, the largest is North America (this report) at $20.16 Bn.
  • Fastest growing: Africa at 8.7% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$13.61 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Veterinary Drugs Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $19.04 Bn — —
2025 (base) $20.16 Bn +$1.12 Bn —
2026 (forecast) $21.35 Bn +$1.19 Bn +5.9%
2027 (forecast) $22.61 Bn +$1.26 Bn +12.1%
2028 (forecast) $23.95 Bn +$1.33 Bn +18.8%
2029 (forecast) $25.36 Bn +$1.41 Bn +25.8%
2030 (forecast) $26.86 Bn +$1.50 Bn +33.2%
2031 (forecast) $28.44 Bn +$1.58 Bn +41.1%
2032 (forecast) $30.12 Bn +$1.68 Bn +49.4%
2033 (forecast) $31.90 Bn +$1.78 Bn +58.2%
2034 (forecast) $33.78 Bn +$1.88 Bn +67.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Veterinary Drugs Market Analysis at a glance
Market size, 2025$20.16 Bn placeholder estimate
Forecast, 2034$33.78 Bn placeholder estimate
Growth (CAGR), 2025–20345.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and animal (see all)
Key playersZoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Veterinary Drugs Market Analysis Executive Summary

Veterinary drugs are the medicines given to pets and farm animals to treat or prevent disease and pain.

Key segments of the veterinary drugs market include product (Anti-Infectives, Anti-Parasitics and Anti-Inflammatories) and animal (Dogs, Cats and Cattle).

Bar chart: North America Veterinary Drugs market size, 2024–2034, placeholder estimates. $19.04 Bn in 2024, $20.16 Bn in 2025 and $33.78 Bn in 2034, 5.9% CAGR.
North America Veterinary Drugs market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Veterinary Drugs Market Dynamics

Market Growth Drivers

More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.

Opportunity

Long-acting treatments, tests that find disease early and growing pet spending in emerging countries give the veterinary drugs market room to grow.

Market Restraints

Rules on antibiotic use in farm animals, high drug prices for pet owners and shortages of vets in rural areas hold back the veterinary drugs market.

Competitive Landscape for Veterinary Drugs Market in North America

The veterinary drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Veterinary Drugs Market in North America

Veterinary Drugs in North America: rules and payment

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4].

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for veterinary drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Veterinary Drugs right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Veterinary Drugs in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Veterinary Drugs market in North America?
Placeholder estimate: about $20.16 Bn in 2025, rising to about $33.78 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Veterinary Drugs market in North America growing?
Placeholder estimate: about 5.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Veterinary Drugs market report cover?
The report splits the market by product (Anti-Infectives, Anti-Parasitics, Anti-Inflammatories, Vaccines and more) and animal (Dogs, Cats, Cattle, Poultry and more).
Who are the key players in the Veterinary Drugs market?
Key players include Zoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and Virbac.
What is driving the Veterinary Drugs market?
More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.
How much research is published on Veterinary Drugs?
PubMed lists 556 papers on Veterinary Drugs added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 21 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in North America

See all

Related on animal health

See the topic